Staging β-Amyloid Pathology With Amyloid Positron Emission Tomography

This multicenter longitudinal cohort study of 741 participants uses in vivo β-amyloid cerebrospinal fluid and positron emission tomography findings to track progression of Alzheimer disease across 6 years of follow-up.

https://jamanetwork.com/journals/jamaneurology/fullarticle/2738356

Source: JAMA Neurology - July 17, 2019 Category: Neurology Source Type: research